Agarwal A K, Jain Vineet, Singla Sumeet, Baruah B P, Arya Vivek, Yadav Rajbala, Singh Vivek Pal
Department of Medicine, Post Graduate Institute of Medical Education and Research, Dr. R M L Hospital, New Delhi-110001.
J Assoc Physicians India. 2011 Jun;59:351-4.
To estimate the prevalence of non-alcoholic fatty liver disease (NAFLD) by ultrasonography, and to correlate NAFLD with coronary artery disease (CAD) and coronary risk factors in a group of Indian type 2 diabetics.
Consecutive patients of type 2 diabetes were recruited. History and physical examination were recorded. Laboratory investigations included fasting and 2-hour post-prandial blood glucose, blood urea, serum creatinine, liver function tests, lipid profile, glycated haemoglobin, microalbuminuria, and ultrasonographic measurement of carotid intimal-medial thickness (CIMT). NAFLD was diagnosed on the basis of ultrasound assessment of the liver.
The study group (n=124) was divided into a NAFLD group (n=71) and a non-NAFLD group (n=53). The prevalence of NAFLD was 57.2%. CAD was more prevalent in the NAFLD subgroup (60.5%) compared to the non-NAFLD subgroup (45.2%). The NAFLD subgroup had higher prevalence of hypertension, smoking, obesity (measured by BMI), central obesity (measured by waist circumference and waist hip ratio), higher HbAlc, higher triglyceride levels and lower HDL levels, and higher mean CIMT. Using binary logistic regression analysis, it was found that hypertension (p=0.013), LDL cholesterol (p=0.049), microalbuminuria (p=0.034) and NAFLD (p=0.016) were significantly correlated with CAD.
Among type 2 diabetics, NAFLD clusters with traditional coronary risk factors. It is a surrogate and fairly reliable marker of risk for CAD amongst type 2 diabetic patients. Ultrasonographically detected NAFLD is a simple, cheap, and safely assessable parameter for coronary risk stratification in type 2 diabetics.
通过超声检查评估非酒精性脂肪性肝病(NAFLD)的患病率,并将一组印度2型糖尿病患者的NAFLD与冠状动脉疾病(CAD)及冠状动脉危险因素进行关联分析。
招募2型糖尿病连续病例。记录病史和体格检查结果。实验室检查包括空腹及餐后2小时血糖、血尿素、血清肌酐、肝功能检查、血脂谱、糖化血红蛋白、微量白蛋白尿,以及颈动脉内膜中层厚度(CIMT)的超声测量。根据肝脏超声评估诊断NAFLD。
研究组(n = 124)分为NAFLD组(n = 71)和非NAFLD组(n = 53)。NAFLD患病率为57.2%。与非NAFLD亚组(45.2%)相比,NAFLD亚组CAD更为普遍(60.5%)。NAFLD亚组高血压、吸烟、肥胖(通过BMI衡量)、中心性肥胖(通过腰围和腰臀比衡量)、更高的糖化血红蛋白、更高的甘油三酯水平和更低的高密度脂蛋白水平以及更高的平均CIMT患病率更高。采用二元逻辑回归分析发现,高血压(p = 0.013)、低密度脂蛋白胆固醇(p = 0.049)、微量白蛋白尿(p = 0.034)和NAFLD(p = 0.016)与CAD显著相关。
在2型糖尿病患者中NAFLD与传统冠状动脉危险因素聚集。它是2型糖尿病患者CAD风险的替代且相当可靠的标志物。超声检测到的NAFLD是2型糖尿病患者冠状动脉风险分层的简单、廉价且安全可评估的参数。